Industry Research Reports
Home > Reports > Medical Care > Global Circulating Tumor Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Global Circulating Tumor Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Industry: Medical Care
Published Date: 2024-04-16
Pages: 167 Pages
Report ld: 2682149
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Circulating Tumor Cells Market Size(US$)
CAGR 2024-2030
20.4%
Market Size,2030
USD 5,895.4
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 1,935.3 million
Market Forecast in 2030(Value)
US$ 5,895.4 million
CAGR
20.4%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The global market for Circulating Tumor Cells was estimated to be worth US$ 1584.6 million in 2023 and is forecast to a readjusted size of US$ 5895.4 million by 2030 with a CAGR of 20.4% during the forecast period 2024-2030.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
MARKET SEGMENTATION
By Company
- Menarini-Silicon Biosystems
- Qiagen (Adnagen)
- Advanced Cell Diagnostics
- ApoCell
- Epic Sciences
- Greiner Bio-one GmbH
- Cynvenio
- SurExamBio-Tech
- Fluxion Biosciences
- Ikonisys
- Hangzhou Watson Biotech
- Biocept
- CytoTrack
- Guangzhou Wondfo Biotech
- Celsee
- Clearbridge Biomedics
- ANGLE plc
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- CTC Enrichment
- CTC Detection
- CTC Analysis
Segment by Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Lung Cancer
- Others
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells.
The Circulating Tumor Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cells market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Circulating Tumor Cells in global and regional level.
Chapter 3: Detailed analysis of Circulating Tumor Cells company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Circulating Tumor Cells revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Circulating Tumor Cells Product Introduction
1.2 Market by Type
1.2.1 Global Circulating Tumor Cells Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Circulating Tumor Cells Market Size Estimates and Forecasts
2.2 Circulating Tumor Cells Market Size by Region: 2023 Versus 2030
2.2.1 Global Circulating Tumor Cells Revenue by Region: 2019-2024
2.2.2 Global Circulating Tumor Cells Revenue Forecast by Region (2025-2030)
2.2.3 Global Circulating Tumor Cells Revenue Market Share by Region (2019-2030)
3 Global Circulating Tumor Cells by Company
3.1 Global Circulating Tumor Cells Revenue by Company (2019-2024)
3.2 Global Circulating Tumor Cells Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Circulating Tumor Cells Companies around the World: Ranking by Revenue
3.3.2 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Circulating Tumor Cells Companies Headquarters & Product Type
3.4.1 Circulating Tumor Cells Companies Headquarters
3.4.2 Global Circulating Tumor Cells Companies Product & Service
3.4.3 Date of International Companies Enter into Circulating Tumor Cells Market
3.5 Global Circulating Tumor Cells Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Menarini-Silicon Biosystems
4.1.1 Menarini-Silicon Biosystems Company Information
4.1.2 Menarini-Silicon Biosystems Description, Business Overview
4.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Products Offered
4.1.4 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.1.5 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue by Product in 2023
4.1.6 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue by Application in 2023
4.1.7 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue by Geographic Area in 2023
4.1.8 Menarini-Silicon Biosystems Recent Developments
4.2 Qiagen (Adnagen)
4.2.1 Qiagen (Adnagen) Company Information
4.2.2 Qiagen (Adnagen) Description, Business Overview
4.2.3 Qiagen (Adnagen) Circulating Tumor Cells Products Offered
4.2.4 Qiagen (Adnagen) Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.2.5 Qiagen (Adnagen) Circulating Tumor Cells Revenue by Product in 2023
4.2.6 Qiagen (Adnagen) Circulating Tumor Cells Revenue by Application in 2023
4.2.7 Qiagen (Adnagen) Circulating Tumor Cells Revenue by Geographic Area in 2023
4.2.8 Qiagen (Adnagen) Recent Developments
4.3 Advanced Cell Diagnostics
4.3.1 Advanced Cell Diagnostics Company Information
4.3.2 Advanced Cell Diagnostics Description, Business Overview
4.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Products Offered
4.3.4 Advanced Cell Diagnostics Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.3.5 Advanced Cell Diagnostics Circulating Tumor Cells Revenue by Product in 2023
4.3.6 Advanced Cell Diagnostics Circulating Tumor Cells Revenue by Application in 2023
4.3.7 Advanced Cell Diagnostics Circulating Tumor Cells Revenue by Geographic Area in 2023
4.3.8 Advanced Cell Diagnostics Recent Developments
4.4 ApoCell
4.4.1 ApoCell Company Information
4.4.2 ApoCell Description, Business Overview
4.4.3 ApoCell Circulating Tumor Cells Products Offered
4.4.4 ApoCell Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.4.5 ApoCell Circulating Tumor Cells Revenue by Product in 2023
4.4.6 ApoCell Circulating Tumor Cells Revenue by Application in 2023
4.4.7 ApoCell Circulating Tumor Cells Revenue by Geographic Area in 2023
4.4.8 ApoCell Recent Developments
4.5 Epic Sciences
4.5.1 Epic Sciences Company Information
4.5.2 Epic Sciences Description, Business Overview
4.5.3 Epic Sciences Circulating Tumor Cells Products Offered
4.5.4 Epic Sciences Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.5.5 Epic Sciences Circulating Tumor Cells Revenue by Product in 2023
4.5.6 Epic Sciences Circulating Tumor Cells Revenue by Application in 2023
4.5.7 Epic Sciences Circulating Tumor Cells Revenue by Geographic Area in 2023
4.5.8 Epic Sciences Recent Developments
4.6 Greiner Bio-one GmbH
4.6.1 Greiner Bio-one GmbH Company Information
4.6.2 Greiner Bio-one GmbH Description, Business Overview
4.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Products Offered
4.6.4 Greiner Bio-one GmbH Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.6.5 Greiner Bio-one GmbH Circulating Tumor Cells Revenue by Product in 2023
4.6.6 Greiner Bio-one GmbH Circulating Tumor Cells Revenue by Application in 2023
4.6.7 Greiner Bio-one GmbH Circulating Tumor Cells Revenue by Geographic Area in 2023
4.6.8 Greiner Bio-one GmbH Recent Development
4.7 Cynvenio
4.7.1 Cynvenio Company Information
4.7.2 Cynvenio Description, Business Overview
4.7.3 Cynvenio Circulating Tumor Cells Products Offered
4.7.4 Cynvenio Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.7.5 Cynvenio Circulating Tumor Cells Revenue by Product in 2023
4.7.6 Cynvenio Circulating Tumor Cells Revenue by Application in 2023
4.7.7 Cynvenio Circulating Tumor Cells Revenue by Geographic Area in 2023
4.7.8 Cynvenio Recent Development
4.8 SurExamBio-Tech
4.8.1 SurExamBio-Tech Company Information
4.8.2 SurExamBio-Tech Description, Business Overview
4.8.3 SurExamBio-Tech Circulating Tumor Cells Products Offered
4.8.4 SurExamBio-Tech Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.8.5 SurExamBio-Tech Circulating Tumor Cells Revenue by Product in 2023
4.8.6 SurExamBio-Tech Circulating Tumor Cells Revenue by Application in 2023
4.8.7 SurExamBio-Tech Circulating Tumor Cells Revenue by Geographic Area in 2023
4.8.8 SurExamBio-Tech Recent Development
4.9 Fluxion Biosciences
4.9.1 Fluxion Biosciences Company Information
4.9.2 Fluxion Biosciences Description, Business Overview
4.9.3 Fluxion Biosciences Circulating Tumor Cells Products Offered
4.9.4 Fluxion Biosciences Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.9.5 Fluxion Biosciences Circulating Tumor Cells Revenue by Product in 2023
4.9.6 Fluxion Biosciences Circulating Tumor Cells Revenue by Application in 2023
4.9.7 Fluxion Biosciences Circulating Tumor Cells Revenue by Geographic Area in 2023
4.9.8 Fluxion Biosciences Recent Development
4.10 Ikonisys
4.10.1 Ikonisys Company Information
4.10.2 Ikonisys Description, Business Overview
4.10.3 Ikonisys Circulating Tumor Cells Products Offered
4.10.4 Ikonisys Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.10.5 Ikonisys Circulating Tumor Cells Revenue by Product in 2023
4.10.6 Ikonisys Circulating Tumor Cells Revenue by Application in 2023
4.10.7 Ikonisys Circulating Tumor Cells Revenue by Geographic Area in 2023
4.10.8 Ikonisys Recent Development
4.11 Hangzhou Watson Biotech
4.11.1 Hangzhou Watson Biotech Company Information
4.11.2 Hangzhou Watson Biotech Description, Business Overview
4.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Products Offered
4.11.4 Hangzhou Watson Biotech Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.11.5 Hangzhou Watson Biotech Circulating Tumor Cells Revenue by Product in 2023
4.11.6 Hangzhou Watson Biotech Circulating Tumor Cells Revenue by Application in 2023
4.11.7 Hangzhou Watson Biotech Circulating Tumor Cells Revenue by Geographic Area in 2023
4.11.8 Hangzhou Watson Biotech Recent Development
4.12 Biocept
4.12.1 Biocept Company Information
4.12.2 Biocept Description, Business Overview
4.12.3 Biocept Circulating Tumor Cells Products Offered
4.12.4 Biocept Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.12.5 Biocept Circulating Tumor Cells Revenue by Product in 2023
4.12.6 Biocept Circulating Tumor Cells Revenue by Application in 2023
4.12.7 Biocept Circulating Tumor Cells Revenue by Geographic Area in 2023
4.12.8 Biocept Recent Development
4.13 CytoTrack
4.13.1 CytoTrack Company Information
4.13.2 CytoTrack Description, Business Overview
4.13.3 CytoTrack Circulating Tumor Cells Products Offered
4.13.4 CytoTrack Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.13.5 CytoTrack Circulating Tumor Cells Revenue by Product in 2023
4.13.6 CytoTrack Circulating Tumor Cells Revenue by Application in 2023
4.13.7 CytoTrack Circulating Tumor Cells Revenue by Geographic Area in 2023
4.13.8 CytoTrack Recent Development
4.14 Guangzhou Wondfo Biotech
4.14.1 Guangzhou Wondfo Biotech Company Information
4.14.2 Guangzhou Wondfo Biotech Description, Business Overview
4.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Products Offered
4.14.4 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.14.5 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue by Product in 2023
4.14.6 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue by Application in 2023
4.14.7 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue by Geographic Area in 2023
4.14.8 Guangzhou Wondfo Biotech Recent Development
4.15 Celsee
4.15.1 Celsee Company Information
4.15.2 Celsee Description, Business Overview
4.15.3 Celsee Circulating Tumor Cells Products Offered
4.15.4 Celsee Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.15.5 Celsee Circulating Tumor Cells Revenue by Product in 2023
4.15.6 Celsee Circulating Tumor Cells Revenue by Application in 2023
4.15.7 Celsee Circulating Tumor Cells Revenue by Geographic Area in 2023
4.15.8 Celsee Recent Development
4.16 Clearbridge Biomedics
4.16.1 Clearbridge Biomedics Company Information
4.16.2 Clearbridge Biomedics Description, Business Overview
4.16.3 Clearbridge Biomedics Circulating Tumor Cells Products Offered
4.16.4 Clearbridge Biomedics Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.16.5 Clearbridge Biomedics Circulating Tumor Cells Revenue by Product in 2023
4.16.6 Clearbridge Biomedics Circulating Tumor Cells Revenue by Application in 2023
4.16.7 Clearbridge Biomedics Circulating Tumor Cells Revenue by Geographic Area in 2023
4.16.8 Clearbridge Biomedics Recent Development
4.17 ANGLE plc
4.17.1 ANGLE plc Company Information
4.17.2 ANGLE plc Description, Business Overview
4.17.3 ANGLE plc Circulating Tumor Cells Products Offered
4.17.4 ANGLE plc Circulating Tumor Cells Revenue and Gross Margin (2019-2024)
4.17.5 ANGLE plc Circulating Tumor Cells Revenue by Product in 2023
4.17.6 ANGLE plc Circulating Tumor Cells Revenue by Application in 2023
4.17.7 ANGLE plc Circulating Tumor Cells Revenue by Geographic Area in 2023
4.17.8 ANGLE plc Recent Development
5 Breakdown Data by Type
5.1 Global Circulating Tumor Cells Revenue by Type (2019-2024)
5.2 Global Circulating Tumor Cells Revenue Forecast by Type (2025-2030)
5.3 Circulating Tumor Cells Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Circulating Tumor Cells Revenue by Application (2019-2024)
6.2 Global Circulating Tumor Cells Revenue Forecast by Application (2025-2030)
6.3 Circulating Tumor Cells Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Circulating Tumor Cells Market Size YoY Growth 2019-2030
7.2 North America Circulating Tumor Cells Market Facts & Figures by Country (2019-2030)
7.3 North America Circulating Tumor Cells Revenue by Type (2019-2024)
7.4 North America Circulating Tumor Cells Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Circulating Tumor Cells Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Circulating Tumor Cells Revenue by Type (2019-2024)
8.4 Asia-Pacific Circulating Tumor Cells Revenue by Application (2019-2024)
9 Europe
9.1 Europe Circulating Tumor Cells Market Size YoY Growth 2019-2030
9.2 Europe Circulating Tumor Cells Market Facts & Figures by Country (2019-2030)
9.3 Europe Circulating Tumor Cells Revenue by Type (2019-2024)
9.4 Europe Circulating Tumor Cells Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Circulating Tumor Cells Market Size YoY Growth 2019-2030
10.2 Latin America Circulating Tumor Cells Market Facts & Figures by Country (2019-2030)
10.3 Latin America Circulating Tumor Cells Revenue by Type (2019-2024)
10.4 Latin America Circulating Tumor Cells Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Circulating Tumor Cells Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Circulating Tumor Cells Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Circulating Tumor Cells Revenue by Type (2019-2024)
11.4 Middle East and Africa Circulating Tumor Cells Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Circulating Tumor Cells Supply Chain Analysis
12.2 Circulating Tumor Cells Key Raw Materials and Upstream Suppliers
12.3 Circulating Tumor Cells Clients Analysis
12.4 Circulating Tumor Cells Sales Channel and Sales Model Analysis
12.4.1 Circulating Tumor Cells Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Circulating Tumor Cells Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Circulating Tumor Cells Distributors
13 Market Dynamics
13.1 Circulating Tumor Cells Industry Trends
13.2 Circulating Tumor Cells Market Drivers
13.3 Circulating Tumor Cells Market Challenges
13.4 Circulating Tumor Cells Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Circulating Tumor Cells Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Major Companies of CTC Enrichment
Table 3. Major Companies of CTC Detection
Table 4. Major Companies of CTC Analysis
Table 5. Global Circulating Tumor Cells Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Circulating Tumor Cells Market Size by Region (US$ Million): 2023 VS 2030
Table 7. Global Circulating Tumor Cells Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Circulating Tumor Cells Revenue Forecast by Region (2025-2030) & (US$ Million)
Table 9. Circulating Tumor Cells Revenue by Company (2019-2024) & (US$ Million)
Table 10. Circulating Tumor Cells Revenue Share by Company (2019-2024)
Table 11. Ranking of Global Top Circulating Tumor Cells Players by Revenue (US$ Million) in 2023
Table 12. Global Circulating Tumor Cells Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)
Table 13. Global Circulating Tumor Cells by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2023)
Table 14. Global Circulating Tumor Cells Companies Headquarters
Table 15. Global Circulating Tumor Cells Companies Product & Service
Table 16. Date of International Companies Enter into Circulating Tumor Cells Market
Table 17. Global Circulating Tumor Cells Mergers & Acquisitions, Expansion Plans
Table 18. Menarini-Silicon Biosystems Company Information
Table 19. Menarini-Silicon Biosystems Description and Business Overview
Table 20. Menarini-Silicon Biosystems Circulating Tumor Cells Product
Table 21. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 22. Menarini-Silicon Biosystems Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 23. Menarini-Silicon Biosystems Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 24. Menarini-Silicon Biosystems Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 25. Menarini-Silicon Biosystems Recent Development
Table 26. Qiagen (Adnagen) Company Information
Table 27. Qiagen (Adnagen) Description and Business Overview
Table 28. Qiagen (Adnagen) Circulating Tumor Cells Product
Table 29. Qiagen (Adnagen) Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 30. Qiagen (Adnagen) Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 31. Qiagen (Adnagen) Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 32. Qiagen (Adnagen) Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 33. Qiagen (Adnagen) Recent Development
Table 34. Advanced Cell Diagnostics Company Information
Table 35. Advanced Cell Diagnostics Description and Business Overview
Table 36. Advanced Cell Diagnostics Circulating Tumor Cells Product
Table 37. Advanced Cell Diagnostics Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 38. Advanced Cell Diagnostics Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 39. Advanced Cell Diagnostics Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 40. Advanced Cell Diagnostics Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 41. Advanced Cell Diagnostics Recent Development
Table 42. ApoCell Company Information
Table 43. ApoCell Description and Business Overview
Table 44. ApoCell Circulating Tumor Cells Product
Table 45. ApoCell Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 46. ApoCell Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 47. ApoCell Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 48. ApoCell Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 49. ApoCell Recent Development
Table 50. Epic Sciences Company Information
Table 51. Epic Sciences Description and Business Overview
Table 52. Epic Sciences Circulating Tumor Cells Product
Table 53. Epic Sciences Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 54. Epic Sciences Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 55. Epic Sciences Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 56. Epic Sciences Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 57. Epic Sciences Recent Development
Table 58. Greiner Bio-one GmbH Company Information
Table 59. Greiner Bio-one GmbH Description and Business Overview
Table 60. Greiner Bio-one GmbH Circulating Tumor Cells Product
Table 61. Greiner Bio-one GmbH Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 62. Greiner Bio-one GmbH Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 63. Greiner Bio-one GmbH Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 64. Greiner Bio-one GmbH Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 65. Greiner Bio-one GmbH Recent Development
Table 66. Cynvenio Company Information
Table 67. Cynvenio Description and Business Overview
Table 68. Cynvenio Circulating Tumor Cells Product
Table 69. Cynvenio Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. Cynvenio Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 71. Cynvenio Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 72. Cynvenio Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 73. Cynvenio Recent Development
Table 74. SurExamBio-Tech Company Information
Table 75. SurExamBio-Tech Description and Business Overview
Table 76. SurExamBio-Tech Circulating Tumor Cells Product
Table 77. SurExamBio-Tech Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. SurExamBio-Tech Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 79. SurExamBio-Tech Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 80. SurExamBio-Tech Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 81. SurExamBio-Tech Recent Development
Table 82. Fluxion Biosciences Company Information
Table 83. Fluxion Biosciences Description and Business Overview
Table 84. Fluxion Biosciences Circulating Tumor Cells Product
Table 85. Fluxion Biosciences Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Fluxion Biosciences Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 87. Fluxion Biosciences Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 88. Fluxion Biosciences Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 89. Fluxion Biosciences Recent Development
Table 90. Ikonisys Company Information
Table 91. Ikonisys Description and Business Overview
Table 92. Ikonisys Circulating Tumor Cells Product
Table 93. Ikonisys Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 94. Ikonisys Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 95. Ikonisys Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 96. Ikonisys Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 97. Ikonisys Recent Development
Table 98. Hangzhou Watson Biotech Company Information
Table 99. Hangzhou Watson Biotech Description and Business Overview
Table 100. Hangzhou Watson Biotech Circulating Tumor Cells Product
Table 101. Hangzhou Watson Biotech Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 102. Hangzhou Watson Biotech Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 103. Hangzhou Watson Biotech Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 104. Hangzhou Watson Biotech Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 105. Hangzhou Watson Biotech Recent Development
Table 106. Biocept Company Information
Table 107. Biocept Description and Business Overview
Table 108. Biocept Circulating Tumor Cells Product
Table 109. Biocept Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 110. Biocept Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 111. Biocept Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 112. Biocept Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 113. Biocept Recent Development
Table 114. CytoTrack Company Information
Table 115. CytoTrack Description and Business Overview
Table 116. CytoTrack Circulating Tumor Cells Product
Table 117. CytoTrack Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 118. CytoTrack Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 119. CytoTrack Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 120. CytoTrack Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 121. CytoTrack Recent Development
Table 122. Guangzhou Wondfo Biotech Company Information
Table 123. Guangzhou Wondfo Biotech Description and Business Overview
Table 124. Guangzhou Wondfo Biotech Circulating Tumor Cells Product
Table 125. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 126. Guangzhou Wondfo Biotech Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 127. Guangzhou Wondfo Biotech Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 128. Guangzhou Wondfo Biotech Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 129. Guangzhou Wondfo Biotech Recent Development
Table 130. Celsee Company Information
Table 131. Celsee Description and Business Overview
Table 132. Celsee Circulating Tumor Cells Product
Table 133. Celsee Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 134. Celsee Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 135. Celsee Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 136. Celsee Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 137. Celsee Recent Development
Table 138. Clearbridge Biomedics Company Information
Table 139. Clearbridge Biomedics Description and Business Overview
Table 140. Clearbridge Biomedics Circulating Tumor Cells Product
Table 141. Clearbridge Biomedics Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 142. Clearbridge Biomedics Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 143. Clearbridge Biomedics Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 144. Clearbridge Biomedics Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 145. Clearbridge Biomedics Recent Development
Table 146. ANGLE plc Company Information
Table 147. ANGLE plc Description and Business Overview
Table 148. ANGLE plc Circulating Tumor Cells Product
Table 149. ANGLE plc Circulating Tumor Cells Revenue (US$ Million) and Gross Margin (2019-2024)
Table 150. ANGLE plc Revenue Proportion of Circulating Tumor Cells by Product in 2023
Table 151. ANGLE plc Revenue Proportion of Circulating Tumor Cells by Application in 2023
Table 152. ANGLE plc Revenue Proportion of Circulating Tumor Cells by Geographic Area in 2023
Table 153. ANGLE plc Recent Development
Table 154. Global Circulating Tumor Cells Revenue by Type (2019-2024) & (US$ Million)
Table 155. Global Circulating Tumor Cells Revenue Forecast by Type (2025-2030) & (US$ Million)
Table 156. Global Circulating Tumor Cells Revenue by Application (2019-2024) & (US$ Million)
Table 157. Global Circulating Tumor Cells Revenue Forecast by Application (2025-2030) & (US$ Million)
Table 158. North America Circulating Tumor Cells Revenue by Country (2019-2024) & (US$ Million)
Table 159. North America Circulating Tumor Cells Revenue by Country (2025-2030) & (US$ Million)
Table 160. North America Circulating Tumor Cells Revenue by Type (2019-2024) & (US$ Million)
Table 161. North America Circulating Tumor Cells Revenue by Application (2019-2024) & (US$ Million)
Table 162. Asia-Pacific Circulating Tumor Cells Revenue by Region (2019-2030) & (US$ Million)
Table 163. Asia-Pacific Circulating Tumor Cells Revenue by Region (2025-2030) & (US$ Million)
Table 164. Asia-Pacific Circulating Tumor Cells Revenue by Type (2019-2024) & (US$ Million)
Table 165. Asia-Pacific Circulating Tumor Cells Revenue by Application (2019-2024) & (US$ Million)
Table 166. Europe Circulating Tumor Cells Revenue by Country (2019-2024) & (US$ Million)
Table 167. Europe Circulating Tumor Cells Revenue by Country (2025-2030) & (US$ Million)
Table 168. Europe Circulating Tumor Cells Revenue by Type (2019-2024) & (US$ Million)
Table 169. Europe Circulating Tumor Cells Revenue by Application (2019-2024) & (US$ Million)
Table 170. Latin America Circulating Tumor Cells Revenue by Country (2019-2024) & (US$ Million)
Table 171. Latin America Circulating Tumor Cells Revenue by Country (2025-2030) & (US$ Million)
Table 172. Latin America Circulating Tumor Cells Revenue by Type (2019-2024) & (US$ Million)
Table 173. Latin America Circulating Tumor Cells Revenue by Application (2019-2024) & (US$ Million)
Table 174. Middle East and Africa Circulating Tumor Cells Revenue by Country (2019-2024) & (US$ Million)
Table 175. Middle East and Africa Circulating Tumor Cells Revenue by Country (2025-2030) & (US$ Million)
Table 176. Middle East and Africa Circulating Tumor Cells Revenue by Type (2019-2024) & (US$ Million)
Table 177. Middle East and Africa Circulating Tumor Cells Revenue by Application (2019-2024) & (US$ Million)
Table 178. Circulating Tumor Cells Key Raw Materials, Industry Status and Trend
Table 179. Circulating Tumor Cells Key Raw Materials and Upstream Suppliers
Table 180. Circulating Tumor Cells Clients Status and Trend
Table 181. Circulating Tumor Cells Typical Clients
Table 182. Circulating Tumor Cells Distributors
Table 183. Circulating Tumor Cells Market Trends
Table 184. Circulating Tumor Cells Market Drivers
Table 185. Circulating Tumor Cells Market Challenges
Table 186. Circulating Tumor Cells Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Circulating Tumor Cells Product Picture
Figure 2. Global Circulating Tumor Cells Revenue Market Share by Type in 2023 & 2030
Figure 3. CTC Enrichment Product Picture
Figure 4. CTC Detection Product Picture
Figure 5. CTC Analysis Product Picture
Figure 6. Global Circulating Tumor Cells Revenue Market Share by Application in 2023 & 2030
Figure 7. Breast Cancer
Figure 8. Prostate Cancer
Figure 9. Colorectal Cancer
Figure 10. Lung Cancer
Figure 11. Others
Figure 12. Circulating Tumor Cells Report Years Considered
Figure 13. Global Circulating Tumor Cells Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Circulating Tumor Cells Market Size 2019-2030 (US$ Million)
Figure 15. Global Circulating Tumor Cells Market Size Market Share by Region: 2023 Versus 2030
Figure 16. Global Circulating Tumor Cells Revenue Market Share by Region (2019-2030)
Figure 17. Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 18. Global Circulating Tumor Cells Revenue Market Share Forecast by Type (2019-2030)
Figure 19. Global Circulating Tumor Cells Revenue Market Share Forecast by Application (2019-2030)
Figure 20. North America Circulating Tumor Cells Revenue 2019-2030 (US$ Million)
Figure 21. North America Circulating Tumor Cells Revenue Market Share by Type (2019-2024)
Figure 22. North America Circulating Tumor Cells Revenue Market Share by Application (2019-2024)
Figure 23. Asia-Pacific Circulating Tumor Cells Revenue 2019-2030 (US$ Million)
Figure 24. Asia-Pacific Circulating Tumor Cells Revenue Market Share by Region (2019-2030)
Figure 25. Asia-Pacific Circulating Tumor Cells Revenue Market Share by Type (2019-2024)
Figure 26. Asia-Pacific Circulating Tumor Cells Revenue Market Share by Application (2019-2024)
Figure 27. Europe Circulating Tumor Cells Revenue Growth Rate 2019-2030 (US$ Million)
Figure 28. Europe Circulating Tumor Cells Revenue Market Share by Country (2019-2030)
Figure 29. Europe Circulating Tumor Cells Revenue Market Share by Type (2019-2024)
Figure 30. Europe Circulating Tumor Cells Revenue Market Share by Application (2019-2024)
Figure 31. Latin America Circulating Tumor Cells Revenue Growth Rate 2019-2030 (US$ Million)
Figure 32. Latin America Circulating Tumor Cells Revenue Market Share by Country (2019-2024)
Figure 33. Latin America Circulating Tumor Cells Revenue Market Share by Type (2019-2024)
Figure 34. Latin America Circulating Tumor Cells Revenue Market Share by Application (2019-2024)
Figure 35. Middle East and Africa Circulating Tumor Cells Revenue Growth Rate 2019-2030 (US$ Million)
Figure 36. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Country (2019-2030)
Figure 37. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Type (2019-2024)
Figure 38. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Application (2019-2024)
Figure 39. Circulating Tumor Cells Supply Chain (Upstream and Downstream Market)
Figure 40. Global Production Market Share of Circulating Tumor Cells Raw Materials by Region in 2023
Figure 41. Circulating Tumor Cells Distribution Channels
Figure 42. Global Circulating Tumor Cells Percentage 2019-2030: Indirect Sales VS Direct Sales
Figure 43. Global Circulating Tumor Cells Percentage 2019-2030: Online Sales VS Offline Sales
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Figure 47. Global Circulating Tumor Cells Percentage 2019-2030: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Circulating Tumor Cells in 2030?
The global market size of Circulating Tumor Cells in 2030 was 5895.4 Million USD.
What was the global market size of Circulating Tumor Cells in 2024?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Circulating Tumor Cells market size from 2024 to 2030?
Which companies rank high in the global Circulating Tumor Cells market?
Related Reports
Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Circulating Tumor Cells market size was US$ 2711 million in 2025 and is forecast to reach a readjusted size of US$ 9775 million by 2032 with a CAGR of 20.4% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 110
USD 4250.00
(Single User License)
Global Circulating Tumor Cells Market Research Report 2026
The global Circulating Tumor Cells market was valued at US$ 2711 million in 2025 and is anticipated to reach US$ 9775 million by 2032, at a CAGR of 20.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 134
USD 2900.00
(Single User License)
Circulating Tumor Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Circulating Tumor Cells was estimated to be worth US$ 2711 million in 2025 and is projected to reach US$ 9775 million, growing at a CAGR of 20.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 122
USD 3950.00
(Single User License)
Global Circulating Tumor Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Circulating Tumor Cells market is projected to grow from US$ 2291 million in 2024 to US$ 8259 million by 2031, at a CAGR of 20.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 154
USD 4900.00
(Single User License)
Circulating Tumor Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Circulating Tumor Cells was estimated to be worth US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-08-05
Pages: 127
USD 3950.00
(Single User License)
Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Circulating Tumor Cells market size was US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-08-05
Pages: 109
USD 4250.00
(Single User License)
Global Circulating Tumor Cells Market Research Report 2025
The global market for Circulating Tumor Cells was valued at US$ 2291 million in the year 2024 and is projected to reach a revised size of US$ 8259 million by 2031, growing at a CAGR of 20.4% during the forecast period.
Published Date: 2025-08-05
Pages: 93
USD 2900.00
(Single User License)
Global Circulating Tumor Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Circulating Tumor Cells was estimated to be worth US$ 2291 million and is forecast to reach approximately US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 157
USD 5900.00
(Single User License)
Circulating Tumor Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Circulating Tumor Cells was estimated to be worth US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 125
USD 3950.00
(Single User License)
Global Circulating Tumor Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Published Date: 2024-04-17
Pages: 176
USD 5600.00
(Single User License)
Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Circulating Tumor Cells market size was US$ 2711 million in 2025 and is forecast to reach a readjusted size of US$ 9775 million by 2032 with a CAGR of 20.4% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 110
USD 4250.00 (Single User License)Global Circulating Tumor Cells Market Research Report 2026
The global Circulating Tumor Cells market was valued at US$ 2711 million in 2025 and is anticipated to reach US$ 9775 million by 2032, at a CAGR of 20.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 134
USD 2900.00 (Single User License)Circulating Tumor Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Circulating Tumor Cells was estimated to be worth US$ 2711 million in 2025 and is projected to reach US$ 9775 million, growing at a CAGR of 20.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 122
USD 3950.00 (Single User License)Global Circulating Tumor Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Circulating Tumor Cells market is projected to grow from US$ 2291 million in 2024 to US$ 8259 million by 2031, at a CAGR of 20.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 154
USD 4900.00 (Single User License)Circulating Tumor Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Circulating Tumor Cells was estimated to be worth US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-08-05
Pages: 127
USD 3950.00 (Single User License)Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Circulating Tumor Cells market size was US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-08-05
Pages: 109
USD 4250.00 (Single User License)Global Circulating Tumor Cells Market Research Report 2025
The global market for Circulating Tumor Cells was valued at US$ 2291 million in the year 2024 and is projected to reach a revised size of US$ 8259 million by 2031, growing at a CAGR of 20.4% during the forecast period.
Published: 2025-08-05
Pages: 93
USD 2900.00 (Single User License)Global Circulating Tumor Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Circulating Tumor Cells was estimated to be worth US$ 2291 million and is forecast to reach approximately US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 157
USD 5900.00 (Single User License)Circulating Tumor Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Circulating Tumor Cells was estimated to be worth US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 125
USD 3950.00 (Single User License)Global Circulating Tumor Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Published: 2024-04-17
Pages: 176
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now